Randi Hernandez

BioPharm International

Randi Hernandez was science editor at BioPharm International from September 2014 to May 2017.


Biosafety Concerns of Single-Use Components

Single-use bags containing toxic or hazardous materials required special handling.

CMOs Tackle New Challenges

BioPharm International speaks with a CMO to find out how it is coping with capacity challenges, regulatory authority scrutiny, supply chain reliability, and new requests from clients to incorporate continuous manufacturing into processing lines.

MHRA GMP Report: Quality Systems Still a Top Concern in 2016

The number of deficiencies found in foreign and UK-based facilities increased in 2016.

GE Healthcare: The Next Cell and Gene Therapy Manufacturing Giant?

GE Healthcare continues to ramp up its offerings in the bioprocessing space with the purchase of Asymptote and a continued partnership with Zenith Technologies.

FDA Approves First Treatment for Primary-Progressive Forms of Multiple Sclerosis

The mAb is the first approved treatment that targets the progressive form of the disease.

MIT Professor to Present on Continuous Manufacturing for Biologics at CPhI North America 2017

Richard D. Braatz, PhD, will discuss using mathematical models to design a continuous drug manufacturing plant and the differences between batch and continuous operations for biologics.